PRA Health Sciences (PRAH) Tops Q4 EPS by 5c

PRA Health Sciences (NASDAQ: PRAH) reported Q4 EPS of $0.35, $0.05 better than the analyst estimate of $0.30. Revenue for the quarter came in at $370 million versus the consensus estimate of $323.5 million.

For earnings history and earnings-related data on PRA Health Sciences (PRAH) click here.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• WesBanco (WSBC) Tops Q1 EPS by 1c
• Veritex Holdings (VBTX) Misses Q1 EPS by 2c